Source: Eur Respir J 2010; 36: 1002-1006
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lee H.M., Le H., Lee B.T., Lopez V.A., Wong N.D.. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010; 36: 1002-1006

Member's Comments

No comment yet.

Related content which might interest you: Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Contribution of respiratory disease and smoking to in-hospital mortality Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Source: Eur Respir J 2005; 25: 587-588 Year: 2005 Lung function impairment, COPD hospitalisations and subsequent mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Respiratory symptoms as risk factors for mortality – the Nordic EpiLung Study Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Risk factors for COPD mortality in women in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 463s Year: 2006 Global cardiovascular disease risk score among U.S. adults with asthma Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Lung function and respiratory symptoms as predictors of mortality: The HUNT study Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Meta-analysis of FEV1 as a risk factor for all-cause mortality Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003